RT Journal Article
SR Electronic
T1 Hematological and biochemical predictors of bone marrow metastases in non-hematological malignancies: a clinico-pathological analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.16.20248306
DO 10.1101/2020.12.16.20248306
A1 Agrawal, Shruti
A1 Bhandari, Rekha
A1 Gowda, Vinay N
A1 Gupta, Amit
A1 Singh, Neha
A1 Chowdhury, Nilotpal
A1 Rao, Shalinee
A1 Kishore, Sanjeev
A1 Gupta, Arvind Kumar
A1 Chandra, Harish
YR 2020
UL http://medrxiv.org/content/early/2020/12/19/2020.12.16.20248306.abstract
AB Background Bone marrow metastasis is a significant presentation of many non-hematological malignancies. The present study was conducted with the aim of analysing the clinical, hematological and biochemical parameters of the patients with bone marrow metastases and to determine the parameters which could be possible indicators of bone marrow metastases.Material and methods Bone marrow aspirate, imprint and biopsy slides of 22 cases with bone marrow metastases were reviewed and the hematological and biochemical data of all these cases was compared with that of 20 controls who had no evidence of metastases.Results The mean values of mean platelet volume (MPV), neutrophil to lymphocyte ratio (NLR) and serum lactate dehydrogenase (LDH) were found to be significantly different (p<0.001) between the cases and controls. A MPV<8.1 fL, NLR>3.5 and LDH>452 U/L showed high likelihood ratio in predicting bone marrow metastases.Conclusion Parameters such as MPV, NLR and LDH can be used as efficient and easily available means to predict bone marrow metastasis for an early diagnosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional ethics committe, AIIMS RishikeshAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data mentioned in the manuscript including details of all the cases and controls involved in the study have been mentioned in the manuscript itself.